0000950170-24-064235.txt : 20240523
0000950170-24-064235.hdr.sgml : 20240523
20240523193040
ACCESSION NUMBER: 0000950170-24-064235
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240522
FILED AS OF DATE: 20240523
DATE AS OF CHANGE: 20240523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLARKE JOHN K
CENTRAL INDEX KEY: 0001219015
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 24980377
MAIL ADDRESS:
STREET 1: C/O CARDINAL HEALTH PARTNERS
STREET 2: 221 NASSAU STREET
CITY: PRINCETON
STATE: NJ
ZIP: 08542
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8587318389
MAIL ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
ownership.xml
4
X0508
4
2024-05-22
0001339970
aTYR PHARMA INC
LIFE
0001219015
CLARKE JOHN K
C/O ATYR PHARMA, INC.
10240 SORRENTO VALLEY ROAD, SUITE 300
SAN DIEGO
CA
92121
true
false
false
false
false
Stock Option (right to buy)
1.86
2024-05-22
4
A
false
24000
0.00
A
2034-05-22
Common Stock
24000
24000
D
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.
/s/ Nancy E. Denyes, as Attorney-in-Fact
2024-05-23